AnaprazoleAlternative Names: Anaprazole sodium - Sihuan
Latest Information Update: 29 Oct 2014
At a glance
- Originator Sihuan Pharmaceutical Holdings Group
- Class Antiulcers
- Mechanism of Action Proton pump inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Gastrointestinal ulcer
Most Recent Events
- 30 Jun 2014 Phase-I clinical trials in Gastrointestinal ulcer in China (PO)
- 17 Jul 2013 Preclinical trials in Gastrointestinal ulcer in China (PO)